- Telehealth Visits
- Insurance plan information
Alan W. Shindel, MD, MA
Urology- Telehealth Visits
- Insurance plan information
Urology Parnassus
Alan W. Shindel, MD, MA
UrologyUrology Parnassus
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Urology, American Board of Urology
Fellowship
- Urology, UCSF School of Medicine -GME
Residency
- Urology, Washington University School of Medicine
Internship
- General Surgery, Washington University School of Medicine
Degree
- MD, Washington University School of Medicine in St. Louis
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 72 reviews
Sort by
- March 28, 20265 out of 5 Stars
Excellent discussion of the issue and potential treatments.
- March 20, 20265 out of 5 Stars
They meet all my expectations very good!
- March 19, 20265 out of 5 Stars
Dr. Shindel is at the top of his game!
- January 31, 20265 out of 5 Stars
Excellent listening and providing options for possible resolution of problems.
- January 24, 20265 out of 5 Stars
Verry good
- January 13, 20265 out of 5 Stars
The doctor is always easy to understand in layman's terms.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.